DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

0.15 mg Spinal Morphine vs. no Treatment for Morphine Requirement After VATs.

Information source: Mahidol University
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Postoperative Pain

Intervention: Spinal morphine (Drug)

Phase: Phase 4

Status: Recruiting

Sponsored by: Mahidol University

Official(s) and/or principal investigator(s):
Sirilak Suksompong, MD, Principal Investigator, Affiliation: Mahidol University


Postoperative pain after Video-assisted Thoracoscopic Surgery (VAT) is still debating. Therefore the investigators conduct a study comparing 0. 15 mg spinal morphine and control group in term of analgesia.

Clinical Details

Official title: The Comparison of 0.15 Milligram Spinal Morphine vs.no Treatment for Morphine Requirement After Video-assisted Thoracoscopic Surgery. A Pilot Randomized Control Study

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Primary outcome: Total morphine requirement in 48 hours

Secondary outcome: Pain


Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- Age 18 year or over

- Patient ASA physical status I-III.

- Scheduled for video-assisted thoracoscopic lobectomy or blebectomy with pleurectomy

or pleural abrasion

- Can operate a patient-controlled analgesia (PCA) device.

Exclusion Criteria:

- Known hypersensitivity to morphine

- History of bleeding tendency.

- Known case of infection at the back

- Patient refuse for spinal anesthesia

- History of cerebrovascular disease.

- Need mechanical ventilatory support during postoperative period

Locations and Contacts

Mahidol University, Bangkok 10700, Thailand; Recruiting
Sirilak Suksompong, MD, Phone: 6624113256, Email: sirilak.suk@mahidol.ac.th
Sirilak Suksompong, MD, Principal Investigator
Additional Information

Starting date: February 2014
Last updated: February 23, 2014

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017